Recall
FDAHealthJune 1, 2026

Ascend Laboratories, LLC — Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratori

⚠️ Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 1, 2026

Nationwide in the USA

What's affected?

Product
Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30
Lot code
25141635

Additional details

Lot# 25141635, Exp 4/30/2028

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 360 30-count bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.